Literature DB >> 15100606

Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior.

Pia Bäckström1, Petri Hyytiä.   

Abstract

BACKGROUND: Glutamatergic neurotransmission has been implicated in drug-environment conditioning, but little is known about the role of glutamate in alcohol seeking maintained by alcohol-associated cues. Therefore, we examined the effects of ionotropic glutamate receptor antagonists on cue-induced ethanol-seeking behavior in the extinction/reinstatement model.
METHODS: Rats were trained to orally self-administer ethanol (10% w/v) and a nonrewarding (80 microM) quinine solution on randomly alternating days. Ethanol and quinine availability were signaled by olfactory discriminative stimuli (S+/S-). In addition, ethanol delivery was accompanied by a light stimulus (CS+) and quinine delivery by an auditory stimulus (CS-). Thereafter, rats were subjected to extinction training during which responding had no programmed consequences. Reinstatement of responding was tested under three conditions: in the presence of the S-/CS-, S+/CS+, and S+/CS+ together with a small (0.2 ml) response-contingent oral ethanol dose at the beginning of the reinstatement session (S+/CS+/priming). We examined the effects of the noncompetitive NMDA receptor antagonist MK-801 (0, 0.05, 0.15 mg/kg intraperitoneally), the competitive NMDA antagonist CGP39551 (0, 5, 10 mg/kg intraperitoneally), the NMDA/glycine receptor antagonist L-701,324 (0, 2, 4 mg/kg intraperitoneally), the AMPA/kainate receptor antagonist CNQX (0, 0.5, 1.5 mg/kg intraperitoneally), and the opioid receptor antagonist naltrexone (0, 0.3, 1 mg/kg subcutaneously) on ethanol seeking under the S+/CS+/priming condition.
RESULTS: Presentation of the S+/CS+ stimulus condition reinstated extinguished responding, whereas presentation of the S-/CS- condition did not. Response-contingent ethanol priming enhanced reinstatement further. Under these reinstatement conditions, L-701,324, CNQX, and naltrexone inhibited ethanol-seeking behavior significantly. In contrast, MK-801 and CGP39551 failed to affect reinstated responding.
CONCLUSIONS: These results show that glutamate antagonism suppresses ethanol-seeking behavior induced by ethanol-paired stimuli. Furthermore, the data suggest that ionotropic glutamate receptors may have differential roles in mediation of this behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100606     DOI: 10.1097/01.alc.0000122101.13164.21

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  66 in total

1.  The influence of selection for ethanol withdrawal severity on traits associated with ethanol self-administration and reinforcement.

Authors:  Matthew M Ford; Andrea M Fretwell; Allison M J Anacker; John C Crabbe; Gregory P Mark; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2010-11-10       Impact factor: 3.455

2.  Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats.

Authors:  Hasan Alhaddad; Sujan C Das; Youssef Sari
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530

Review 3.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

4.  Candidate genes and their regulatory elements: alcohol preference and tolerance.

Authors:  Laura Saba; Sanjiv V Bhave; Nicholas Grahame; Paula Bice; Razvan Lapadat; John Belknap; Paula L Hoffman; Boris Tabakoff
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

5.  Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse.

Authors:  Carles Sanchis-Segura; Thilo Borchardt; Valentina Vengeliene; Tarek Zghoul; Daniel Bachteler; Peter Gass; Rolf Sprengel; Rainer Spanagel
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 6.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.

Authors:  Giancarlo Colombo; Alessandro Orrù; Paola Lai; Claudia Cabras; Paola Maccioni; Marina Rubio; Gian Luigi Gessa; Mauro A M Carai
Journal:  Mol Neurobiol       Date:  2007-07-03       Impact factor: 5.590

8.  High Ethanol and Acetaldehyde Inhibit Glutamatergic Transmission in the Hippocampus of Aldh2-Knockout and C57BL/6N Mice: an In Vivo and Ex Vivo Analysis.

Authors:  Mostofa Jamal; Asuka Ito; Naoko Tanaka; Takanori Miki; Kiyoshi Ameno; Hiroshi Kinoshita
Journal:  Neurotox Res       Date:  2020-02-15       Impact factor: 3.911

Review 9.  Identifying the neural circuitry of alcohol craving and relapse vulnerability.

Authors:  Andreas Heinz; Anne Beck; Sabine M Grüsser; Anthony A Grace; Jana Wrase
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

Review 10.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.